Sandor Victor
- SEC CIK
- 0001620368
No open-market purchases or sales filed in the past year.
Current role at each company
- ABCL AbCellera Biologics Inc.Directoras of Jul 6, 2026
- KYMR Kymera Therapeutics, Inc.Directoras of Jun 25, 2026
- PRLD Prelude Therapeutics IncDirectoras of Jun 10, 2026
- ADCT ADC Therapeutics SADirectoras of Jun 3, 2026
- MRUS Merus N.V.Directoras of Dec 12, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Sandor Victor as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ADCT ADC Therapeutics SA
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 18, 2024 (view filing) | Jun 17 | 1 day | Sandor VictorDirector | SSale | −7.00K | $2.89 | −$20.2K | −8.0%80.9K after |